Facilitation of MrgprD by TRP-A1 promotes neuropathic pain

Changming Wang, Leying Gu, Yonglan Ruan, Xiao Geng, Miao Xu, Niuniu Yang, Lei Yu, Yucui Jiang, Chan Zhu, Yan Yang, Yuan Zhou, Xiaowei Guan, Wenqin Luo, Qin Liu, Xinzhong Dong, Guang Yu, Lei Lan, Zongxiang Tang

Research output: Contribution to journalArticle

Abstract

Neuropathic pain remains a therapeutic challenge because of its complicated mechanisms. Mas-related GPCR D (MrgprD) is specifically expressed in small-diameter, nociceptive neurons of dorsal root ganglia (DRGs) and is implicated in pain modulation. However, the underlying mechanism of MrgprD involved in neuropathic pain remains elusive. In this study, we used behavioral experiments and physiologic examination methods to investigate the role of MrgprD in chronic constriction injury (CCI)-induced neuropathic pain. We found that MrgprD is necessary for the initiation of mechanical hypersensitivity and cold allodynia, but not for heat allodynia. Moreover, we demonstrated that transient receptor potential cation channel (TRP)-A1 was the ion channel downstream of MrgprD, and the b-alanine-induced calcium signal was attributed mostly to TRP-A1 function.We further showed that PKA serves as a downstream mediator of b-alanine-activated MrgprD signaling to activate TRP-A1 in DRG neurons and in human embryonic kidney 293 cells, to coexpress MrgprD and TRP-A1 plasmids. Finally, we found that the b-alanine-induced pain behavior was increased, whereas theitching behavior was unchangedin CCI models compared with sham-injured animals. Knockout of TRPA1 also attenuated the b-alanine-induced pain behavior in CCI models. In conclusion, MrgprD is essential in cold allodynia in CCI-induced neuropathic pain through the PKA-TRP-A1 pathway. TRP-A1 facilitates MrgprD to development of neuropathic pain. Our findings reveal a novel mechanism of neuropathic pain formation and highlight MrgprD as a promising drug target for the treatment of neuropathic pain.

Original languageEnglish (US)
Pages (from-to)1360-1373
Number of pages14
JournalFASEB Journal
Volume33
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Neuralgia
Alanine
Constriction
Hyperalgesia
Neurons
Transient Receptor Potential Channels
Wounds and Injuries
Spinal Ganglia
Pain
Ion Channels
Animals
Plasmids
Modulation
Nociceptors
Calcium
Pharmaceutical Preparations
Hot Temperature
Kidney
Experiments
Therapeutics

Keywords

  • Dorsal root ganglia (DRG)
  • MrgprA1
  • Protein kinase A (PKA)

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Wang, C., Gu, L., Ruan, Y., Geng, X., Xu, M., Yang, N., ... Tang, Z. (2019). Facilitation of MrgprD by TRP-A1 promotes neuropathic pain. FASEB Journal, 33(1), 1360-1373. https://doi.org/10.1096/fj.201800615RR

Facilitation of MrgprD by TRP-A1 promotes neuropathic pain. / Wang, Changming; Gu, Leying; Ruan, Yonglan; Geng, Xiao; Xu, Miao; Yang, Niuniu; Yu, Lei; Jiang, Yucui; Zhu, Chan; Yang, Yan; Zhou, Yuan; Guan, Xiaowei; Luo, Wenqin; Liu, Qin; Dong, Xinzhong; Yu, Guang; Lan, Lei; Tang, Zongxiang.

In: FASEB Journal, Vol. 33, No. 1, 01.01.2019, p. 1360-1373.

Research output: Contribution to journalArticle

Wang, C, Gu, L, Ruan, Y, Geng, X, Xu, M, Yang, N, Yu, L, Jiang, Y, Zhu, C, Yang, Y, Zhou, Y, Guan, X, Luo, W, Liu, Q, Dong, X, Yu, G, Lan, L & Tang, Z 2019, 'Facilitation of MrgprD by TRP-A1 promotes neuropathic pain', FASEB Journal, vol. 33, no. 1, pp. 1360-1373. https://doi.org/10.1096/fj.201800615RR
Wang C, Gu L, Ruan Y, Geng X, Xu M, Yang N et al. Facilitation of MrgprD by TRP-A1 promotes neuropathic pain. FASEB Journal. 2019 Jan 1;33(1):1360-1373. https://doi.org/10.1096/fj.201800615RR
Wang, Changming ; Gu, Leying ; Ruan, Yonglan ; Geng, Xiao ; Xu, Miao ; Yang, Niuniu ; Yu, Lei ; Jiang, Yucui ; Zhu, Chan ; Yang, Yan ; Zhou, Yuan ; Guan, Xiaowei ; Luo, Wenqin ; Liu, Qin ; Dong, Xinzhong ; Yu, Guang ; Lan, Lei ; Tang, Zongxiang. / Facilitation of MrgprD by TRP-A1 promotes neuropathic pain. In: FASEB Journal. 2019 ; Vol. 33, No. 1. pp. 1360-1373.
@article{bb8f282bf2594d95adfbcf050c896d33,
title = "Facilitation of MrgprD by TRP-A1 promotes neuropathic pain",
abstract = "Neuropathic pain remains a therapeutic challenge because of its complicated mechanisms. Mas-related GPCR D (MrgprD) is specifically expressed in small-diameter, nociceptive neurons of dorsal root ganglia (DRGs) and is implicated in pain modulation. However, the underlying mechanism of MrgprD involved in neuropathic pain remains elusive. In this study, we used behavioral experiments and physiologic examination methods to investigate the role of MrgprD in chronic constriction injury (CCI)-induced neuropathic pain. We found that MrgprD is necessary for the initiation of mechanical hypersensitivity and cold allodynia, but not for heat allodynia. Moreover, we demonstrated that transient receptor potential cation channel (TRP)-A1 was the ion channel downstream of MrgprD, and the b-alanine-induced calcium signal was attributed mostly to TRP-A1 function.We further showed that PKA serves as a downstream mediator of b-alanine-activated MrgprD signaling to activate TRP-A1 in DRG neurons and in human embryonic kidney 293 cells, to coexpress MrgprD and TRP-A1 plasmids. Finally, we found that the b-alanine-induced pain behavior was increased, whereas theitching behavior was unchangedin CCI models compared with sham-injured animals. Knockout of TRPA1 also attenuated the b-alanine-induced pain behavior in CCI models. In conclusion, MrgprD is essential in cold allodynia in CCI-induced neuropathic pain through the PKA-TRP-A1 pathway. TRP-A1 facilitates MrgprD to development of neuropathic pain. Our findings reveal a novel mechanism of neuropathic pain formation and highlight MrgprD as a promising drug target for the treatment of neuropathic pain.",
keywords = "Dorsal root ganglia (DRG), MrgprA1, Protein kinase A (PKA)",
author = "Changming Wang and Leying Gu and Yonglan Ruan and Xiao Geng and Miao Xu and Niuniu Yang and Lei Yu and Yucui Jiang and Chan Zhu and Yan Yang and Yuan Zhou and Xiaowei Guan and Wenqin Luo and Qin Liu and Xinzhong Dong and Guang Yu and Lei Lan and Zongxiang Tang",
year = "2019",
month = "1",
day = "1",
doi = "10.1096/fj.201800615RR",
language = "English (US)",
volume = "33",
pages = "1360--1373",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "1",

}

TY - JOUR

T1 - Facilitation of MrgprD by TRP-A1 promotes neuropathic pain

AU - Wang, Changming

AU - Gu, Leying

AU - Ruan, Yonglan

AU - Geng, Xiao

AU - Xu, Miao

AU - Yang, Niuniu

AU - Yu, Lei

AU - Jiang, Yucui

AU - Zhu, Chan

AU - Yang, Yan

AU - Zhou, Yuan

AU - Guan, Xiaowei

AU - Luo, Wenqin

AU - Liu, Qin

AU - Dong, Xinzhong

AU - Yu, Guang

AU - Lan, Lei

AU - Tang, Zongxiang

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Neuropathic pain remains a therapeutic challenge because of its complicated mechanisms. Mas-related GPCR D (MrgprD) is specifically expressed in small-diameter, nociceptive neurons of dorsal root ganglia (DRGs) and is implicated in pain modulation. However, the underlying mechanism of MrgprD involved in neuropathic pain remains elusive. In this study, we used behavioral experiments and physiologic examination methods to investigate the role of MrgprD in chronic constriction injury (CCI)-induced neuropathic pain. We found that MrgprD is necessary for the initiation of mechanical hypersensitivity and cold allodynia, but not for heat allodynia. Moreover, we demonstrated that transient receptor potential cation channel (TRP)-A1 was the ion channel downstream of MrgprD, and the b-alanine-induced calcium signal was attributed mostly to TRP-A1 function.We further showed that PKA serves as a downstream mediator of b-alanine-activated MrgprD signaling to activate TRP-A1 in DRG neurons and in human embryonic kidney 293 cells, to coexpress MrgprD and TRP-A1 plasmids. Finally, we found that the b-alanine-induced pain behavior was increased, whereas theitching behavior was unchangedin CCI models compared with sham-injured animals. Knockout of TRPA1 also attenuated the b-alanine-induced pain behavior in CCI models. In conclusion, MrgprD is essential in cold allodynia in CCI-induced neuropathic pain through the PKA-TRP-A1 pathway. TRP-A1 facilitates MrgprD to development of neuropathic pain. Our findings reveal a novel mechanism of neuropathic pain formation and highlight MrgprD as a promising drug target for the treatment of neuropathic pain.

AB - Neuropathic pain remains a therapeutic challenge because of its complicated mechanisms. Mas-related GPCR D (MrgprD) is specifically expressed in small-diameter, nociceptive neurons of dorsal root ganglia (DRGs) and is implicated in pain modulation. However, the underlying mechanism of MrgprD involved in neuropathic pain remains elusive. In this study, we used behavioral experiments and physiologic examination methods to investigate the role of MrgprD in chronic constriction injury (CCI)-induced neuropathic pain. We found that MrgprD is necessary for the initiation of mechanical hypersensitivity and cold allodynia, but not for heat allodynia. Moreover, we demonstrated that transient receptor potential cation channel (TRP)-A1 was the ion channel downstream of MrgprD, and the b-alanine-induced calcium signal was attributed mostly to TRP-A1 function.We further showed that PKA serves as a downstream mediator of b-alanine-activated MrgprD signaling to activate TRP-A1 in DRG neurons and in human embryonic kidney 293 cells, to coexpress MrgprD and TRP-A1 plasmids. Finally, we found that the b-alanine-induced pain behavior was increased, whereas theitching behavior was unchangedin CCI models compared with sham-injured animals. Knockout of TRPA1 also attenuated the b-alanine-induced pain behavior in CCI models. In conclusion, MrgprD is essential in cold allodynia in CCI-induced neuropathic pain through the PKA-TRP-A1 pathway. TRP-A1 facilitates MrgprD to development of neuropathic pain. Our findings reveal a novel mechanism of neuropathic pain formation and highlight MrgprD as a promising drug target for the treatment of neuropathic pain.

KW - Dorsal root ganglia (DRG)

KW - MrgprA1

KW - Protein kinase A (PKA)

UR - http://www.scopus.com/inward/record.url?scp=85059241206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059241206&partnerID=8YFLogxK

U2 - 10.1096/fj.201800615RR

DO - 10.1096/fj.201800615RR

M3 - Article

C2 - 30148678

AN - SCOPUS:85059241206

VL - 33

SP - 1360

EP - 1373

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 1

ER -